Provided by Tiger Trade Technology Pte. Ltd.

HORIZON KINETICS MEDICAL ETF

34.96
-0.1032-0.29%
Post-market: 34.960.00000.00%16:10 EDT
Volume:2K
Turnover:66.28K
Market Cap:16.43M
PE:- -
High:35.10
Open:35.10
Low:34.96
Close:35.06
52wk High:37.90
52wk Low:28.87
Shares:469.95K
Float Shares:469.95K
Volume Ratio:0.73
T/O Rate:0.40%
Dividend:0.41
Dividend Rate:1.17%
ROE:--
ROA:--
PB:--
PE(LYR):- -

Loading ...

Novartis India to Acquire 'Minipress' Trademarks from Pfizer

Reuters
·
Sep 07

Second Clinical Trial Blow in a Week for Novartis as Heart Drug Disappoints, Dragging Down Amgen Shares

Stock News
·
Sep 07

Novartis Heart-Trial Failure Could be Mitigated by Investor Caution

Dow Jones
·
Sep 07

Novartis India - Deal Valued at 12.50 Bln Rupees

THOMSON REUTERS
·
Sep 07

Novartis Shares to Take Hit from Cholesterol Trial Failure

Dow Jones
·
Sep 07

Medical Device Inspection Campaign Launched by Ningyang County Market Regulators

Deep News
·
Sep 07

MedTech Firm Joins Hong Kong Market: Evaluating MEDCAPTAIN's (02041) True Investment Potential

Stock News
·
Sep 07

Dow Jones Top Company Headlines at 9 PM ET: Amazon Cargo Plane Overshoots Runway in Miami, Killing Five People | Carmakers ...

Dow Jones
·
Sep 07

AI-Powered Drug Discovery Heats Up as Innovative Medicines Race Accelerates in Hong Kong Markets

Stock News
·
Sep 07

Sichuan Biokin Pharmaceutical to Engage Investors at Star Market Innovation Drug Sector Earnings Briefing

Deep News
·
Sep 06

Innovative Drug Indices Rally, ETFs See Inflows, CXO and Research Services Show Strong Momentum

Deep News
·
Sep 06

A Novartis Heart Drug Trial Stumbles. Can a Rare-Disease Treatment Lift Shares?

Dow Jones
·
Sep 06

Nvidia, TSMC, Salesforce, CrowdStrike, J&J Insider Shake‑Up

TIPRANKS
·
Sep 05

Plastic Surgery is Booming with Boomers. Here's How to Cash in on the Antiaging Craze.

Dow Jones
·
Sep 05

Brain-Computer Interface Startups Must Walk the Line Between Vast Potential and Near-Term Medical Reality, Says Formatia Founder

Deep News
·
Sep 05

Top Johnson & Johnson Executive Makes Major Stock Move

TIPRANKS
·
Sep 05

Novartis Says Closely Watched Cholesterol Study Failed to Meet Goal

Dow Jones
·
Sep 05

Stocks to Watch: Ionis Pharmaceuticals, Novartis, Corvex

Dow Jones
·
Sep 05

Novartis Pelacarsen Fails Phase III Cardiovascular Outcomes Trial

MT Newswires Live
·
Sep 05

Novartis announces Phase 3 pelacarsen study did not meet primary endpoint

TIPRANKS
·
Sep 05